(Q74595912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Dementia with Lewy bodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Ian G. McKeith

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

519-535

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

The brain-stem lesions in Parkinsonism

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Synucleinopathies: clinical and pathological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Diffuse Lewy body disease in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Parkinson's disease in patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Antemortem diagnosis of diffuse Lewy body disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Neuropsychological deficits associated with diffuse Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

A review of the cognitive and behavioral symptoms in dementia with Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Dementia with lewy bodies: findings from an international multicentre study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Research evaluation and prospective diagnosis of dementia with Lewy bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Donepezil for dementia with Lewy bodies: a case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Dementia with Lewy bodies: response of delirium-like features to donepezil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Donepezil for behavioural disorders associated with Lewy bodies: a case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Lewy bodies and response to tacrine in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Low-dose olanzapine for levodopa induced dyskinesias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Worsening of motor function in Parkinson's disease: a "typical" response to "atypical" antipsychotic medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Delusions associated with elevated muscarinic binding in dementia with Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Pharmacologic treatments of dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900012-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(02)00012-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12171059%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference